These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6974565)
21. Immunological studies in patients with alopecia areata. Herzer P; Czarnetzki BM; Holzmann H; Lemmel EM Int Arch Allergy Appl Immunol; 1979; 58(2):212-8. PubMed ID: 311349 [TBL] [Abstract][Full Text] [Related]
22. Circulating lymphocyte subsets in patients with alopecia areata. Baadsgaard O; Lindskov R Acta Derm Venereol; 1986; 66(3):266-8. PubMed ID: 2426908 [TBL] [Abstract][Full Text] [Related]
23. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata. Igarashi R; Morohashi M; Takeuchi S; Sato Y Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188 [TBL] [Abstract][Full Text] [Related]
25. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata. van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847 [TBL] [Abstract][Full Text] [Related]
26. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata. Igarashi R; Takeuchi S; Sato Y Acta Derm Venereol; 1980; 60(1):33-7. PubMed ID: 6153831 [TBL] [Abstract][Full Text] [Related]
27. Peripheral T-cell subsets in patients with alopecia areata in different clinical phases. Valsecchi R; Bontempelli M; Vicari O; Frigeni A; Foiadelli L; Cainelli T Dermatologica; 1985; 171(3):170-4. PubMed ID: 3908169 [TBL] [Abstract][Full Text] [Related]
28. Increased ratio of helper to suppressor T cells in alopecia areata. Majewski BB; Koh MS; Taylor DR; Watson B; Rhodes EL Br J Dermatol; 1984 Feb; 110(2):171-5. PubMed ID: 6230097 [TBL] [Abstract][Full Text] [Related]
29. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Gilhar A; Landau M; Assy B; Ullmann Y; Shalaginov R; Serafimovich S; Kalish RS Clin Immunol; 2003 Mar; 106(3):181-7. PubMed ID: 12706404 [TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507 [TBL] [Abstract][Full Text] [Related]
31. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction. Gao Z; Jin YQ; Wu W Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931 [TBL] [Abstract][Full Text] [Related]
35. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575 [TBL] [Abstract][Full Text] [Related]
36. Study of peripheral T-cell subpopulations and lymphocyte proliferation in different phases of evolution of alopecia areata. Mak CP; Wu YC; Chang CH; Hsieh RP; Lü YC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):95-103. PubMed ID: 3498608 [TBL] [Abstract][Full Text] [Related]